1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Hyperuricemia: new trials by email Literature Review of Hyperuricemia trials Research Report on Hyperuricemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects. PF-06743649, Placebo - Gout | Phase 1 | Terminated | Pfizer | 30 | 2014-07-01 | 2016-11-11 |
Gout (1)
Arthritis (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Crystal Arthropathies (1) · Genetic Diseases, Inborn (1) · Joint Diseases (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Musculoskeletal Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Purine-Pyrimidine Metabolism, Inborn Errors (1) · Rheumatic Diseases (1)
Pfizer (1)
United States (1)